EGFR and Ventricular arrhythmia: Despite the excellent antitumor effect, EGFR-TKIs could increase the risk of QT interval prolongation, which facilitates ventricular arrhythmia, possibly due to the interaction with potassium channel proteins of cardiomyocytes (8).